Vaxxinity, Inc. is listed today as Vaxxinity, Inc.: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
Funding rounds of Vaxxinity, Inc.| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|
| Mar 2021 | $27 M | No. 1 | $10 to $50 million | | equity | SEC |
| Mar 2021 | $1.4 B | Issued in a merger or acquisition | $1 billion or more | | equity | SEC |
What its filings and its own website say, sentence by sentence, each with its source.
Vaxxinity, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2021).
SEC Form D · Mar 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Mar 2021
No products or services of Vaxxinity, Inc. are on record.
No investor of Vaxxinity, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by Vaxxinity, Inc.| Name | Role | Named in |
|---|
| Mei Mei Hu | Executive officer | Mar 2021 |
| Dakin Sloss | Director | Mar 2021 |
| James Chui | Director | Mar 2021 |
| Louis Reese | Director | Mar 2021 |
| Mei Mei Hu | Director | Mar 2021 |
| Peter Diamandis | Director | Mar 2021 |
Went public since 2021. Its SEC number is that of a company listed on a stock exchange.